GoodRx Holdings (GDRX) Intangibles (2019 - 2026)

GoodRx Holdings has disclosed Intangibles across 8 years of filings, most recently posting $61.2 million for Q1 2026.

• Intangibles for Q1 2026 came in at $61.2 million, down 10.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.2 million (down 10.52% YoY), and the FY2025 annual result was $64.1 million, up 22.99% from the prior year.
• Intangibles came in at $61.2 million for Q1 2026 at GoodRx Holdings, down from $64.1 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $138.3 million in Q2 2025 to a low of $52.1 million in Q4 2024.
• The 5-year median for Intangibles is $89.4 million (2023), against an average of $87.9 million.
• Across the five-year window, Intangibles jumped 220.73% in 2022 and tumbled 48.44% in 2024, its largest moves.
• GoodRx Holdings' Intangibles stood at $119.9 million in 2022, then retreated by 20.38% to $95.4 million in 2023, then tumbled by 45.41% to $52.1 million in 2024, then increased by 22.99% to $64.1 million in 2025, then decreased by 4.55% to $61.2 million in 2026.
• The last three Intangibles figures came in at $61.2 million (Q1 2026), $64.1 million (Q4 2025), and $62.8 million (Q3 2025), per Business Quant data.